Information on Medicines

MeReC publications

The MeReC Bulletin continued to publish 12 issues per year on a monthly basis (see below) and distribute to its core audience of all GPs, health authorities (via each of their prescribing advisers), plus other relevant individuals and organisations throughout England (via each of their prescribing advisers), plus other relevant individuals and organisations throughout England

During 1997, the NPC completed its review of the Bulletin's circulation and distribution arrangements. From January 1998, distribution was improved and extended to include:

a) health authority directors of public health in England

b) all community and hospital pharmacists in England and Wales utilising The Pharmaceutical Journal as a cost-effective and efficient direct mailing route. Previously, copies of the MeReC Bulletin had been circulated to community pharmacies only, via the Pharmaceutical Services Negotiating Committee (PSNC) mailing system, which had increasingly been shown to be of limited effect in providing Bulletin access to both employee and locum community pharmacists.

MeReC Bulletins published in 1997/98

Volume 8 No.4	New guidelines for the treatment of asthma Fluticasone propionate in asthma
Volume 8 No.5	Hormone replacement therapy 2: new preparations
Volume 8 No.6	Moxonidine and valsartan: new antihypertensives
Volume 8 No.7	The `atypical' antipsychotics: clozapine, risperidone, sertindole and olanzapine
Volume 8 No.8	Topical non-steroidal anti-inflammatory drugs: an update
Volume 8 No.9	Urinary incontinence in adults (part 1)
Volume 8 No.10	Acute treatment of migraine: new products
Volume 8 No.11	Urinary incontinence in adults (part 2)
Volume 8 No.12	Fungal nail infections (onychomycosis)
Volume 9 No.1	Management of benign prostatic hyperplasia A `new look' for the MeReC Bulletin
Volume 9 No.2	Atopic eczema and mastalgia: the place of evening primrose oil
Volume 9 No.3	Treatment of seasonal allergic rhinitis (hay fever)